HIV-1 antiretroviral drug therapy

EJ Arts, DJ Hazuda - Cold Spring Harbor …, 2012 - perspectivesinmedicine.cshlp.org
The most significant advance in the medical management of HIV-1 infection has been the
treatment of patients with antiviral drugs, which can suppress HIV-1 replication to …

[HTML][HTML] Modeling the within-host dynamics of HIV infection

AS Perelson, RM Ribeiro - BMC biology, 2013 - Springer
The new field of viral dynamics, based on within-host modeling of viral infections, began with
models of human immunodeficiency virus (HIV), but now includes many viral infections …

[HTML][HTML] Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system

N Rapin, O Lund, M Bernaschi, F Castiglione - PloS one, 2010 - journals.plos.org
We present a new approach to the study of the immune system that combines techniques of
systems biology with information provided by data-driven prediction methods. To this end …

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

TW Chun, L Stuyver, SB Mizell… - Proceedings of the …, 1997 - National Acad Sciences
Although highly active antiretroviral therapy (HAART) in the form of triple combinations of
drugs including protease inhibitors can reduce the plasma viral load of some HIV-1-infected …

Mathematical analysis of HIV-1 dynamics in vivo

AS Perelson, PW Nelson - SIAM review, 1999 - SIAM
Mathematical models have proven valuable in understanding the dynamics of HIV-1
infection in vivo. By comparing these models to data obtained from patients undergoing …

Decay characteristics of HIV-1-infected compartments during combination therapy

AS Perelson, P Essunger, Y Cao, M Vesanen, A Hurley… - Nature, 1997 - nature.com
Abstract Analysis of changes in viral load after initiation of treatment with potent antiretroviral
agents has provided substantial insight into the dynamics of human immunodeficiency virus …

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection

N Goonetilleke, MKP Liu… - Journal of experimental …, 2009 - rupress.org
Identification of the transmitted/founder virus makes possible, for the first time, a genome-
wide analysis of host immune responses against the infecting HIV-1 proteome. A complete …

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

JM Kilby, S Hopkins, TM Venetta, B DiMassimo… - Nature medicine, 1998 - nature.com
T-20, a synthetic peptide corresponding to a region of the transmembrane subunit of the HIV-
1 envelope protein, blocks cell fusion and viral entry at concentrations of less than 2 ng/ml in …

Virus dynamics and drug therapy

S Bonhoeffer, RM May, GM Shaw… - Proceedings of the …, 1997 - National Acad Sciences
The recent development of potent antiviral drugs not only has raised hopes for effective
treatment of infections with HIV or the hepatitis B virus, but also has led to important …

Mathematical analysis of delay differential equation models of HIV-1 infection

PW Nelson, AS Perelson - Mathematical biosciences, 2002 - Elsevier
Models of HIV-1 infection that include intracellular delays are more accurate representations
of the biology and change the estimated values of kinetic parameters when compared to …